Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Med Care Res Rev. 2018 Aug 24;77(4):334–344. doi: 10.1177/1077558718795745

Figure 2. Proportion of hospitals with expected net earnings (Medicare reimbursement revenue gain net of program costs) from an investment in a broad-scale readmission reduction program, by the number of applicable conditions with EXRR>1.

Figure 2.

Broad-scale implementation assumes targeting all patients hospitalized for an HRRP applicable condition, regardless of whether or not a hospital has excess readmissions for all conditions. The numbers are computed across all conditions, by using condition-specific net earnings estimates from Table 3 for conditions with excess readmissions, and only revenue losses from forgone readmissions plus intervention costs for conditions without excess readmissions for which no HRRP penalty savings from further readmission avoidance can be expected. As in Table 3, four permutations of assumptions regarding the effectiveness and costs of the intervention are used. As in Table 3, the number and percentage of hospitals with positive the expected net earnings from a broad-scale readmission reduction intervention.